Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Prostate Cancer
100%
Active Surveillance
100%
Risk of Progression
100%
ERG Protein Expression
100%
Diagnostic Specimen
100%
Confidence Interval
27%
Prostate-specific Antigen
27%
Cox Regression
18%
Working Diagnosis
18%
Cumulative Incidence
18%
Positive Groups
18%
ERG Expression
18%
Positive Cores
18%
Hazard Ratio
9%
High Risk
9%
Diagnostic Information
9%
Statistical Analysis
9%
Measurement Analysis
9%
Significant Predictors
9%
High Incidence
9%
Formalin-fixed
9%
Paraffin Embedding
9%
Clinical Examination
9%
Immunohistochemical Staining
9%
Disease Risk
9%
Prostate Cancer Patients
9%
Watchful Waiting
9%
Tumor Classification
9%
Disease Progression
9%
Clinical Progression
9%
Cause-specific
9%
Risk Model
9%
Ready-to-use
9%
Competing Events
9%
Tissue Biomarkers
9%
Gleason Score
9%
Transrectal Ultrasound
9%
Re-biopsy
9%
Digital Rectal Examination
9%
Aalen-Johansen Estimator
9%
Prostate-specific Antigen Doubling Time
9%
Johansen's Method
9%
Tumor Foci
9%
Multiple Causes
9%
Medicine and Dentistry
Diagnosis
100%
Protein Expression
100%
Prostate Cancer
100%
Prostate Specific Antigen
100%
Transcription Factor ERG
100%
Neoplasm
50%
Biological Marker
50%
Proportional Hazards Model
50%
Cumulative Incidence
50%
Hazard Ratio
25%
Formaldehyde
25%
Clinical Examination
25%
Watchful Waiting
25%
Outcome Assessment
25%
Disease Exacerbation
25%
Gleason Score
25%
Digital Rectal Examination
25%